Avela Health, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Avela Health, Inc. - overview
Established
2024
Location
Carson, CA, US
Primary Industry
Healthcare Specialists
About
Avela Health, Inc. , based in the US, specializes in providing virtual autism evaluations and tailored support services for individuals of all ages, addressing the unique challenges faced by those with autism and related conditions. Founded in 2024, Avela Health, Inc. operates from its headquarters in Carson, US.
The company focuses on delivering specialized autism evaluations and support services. It has successfully completed 2 deals, with the latest funding round being a Seed round in which they raised USD 6. 448 mn. This amount is also the total amount raised by the company to date, reflecting their strategic focus and investment efforts to enhance their service offerings.
Avela Health specializes in delivering virtual autism evaluations and tailored support services for individuals across all age groups, including children, teens, and adults. Their core offerings include comprehensive pediatric and adult evaluations, individual and group therapy, school support services, and access to specialty consultations with experienced clinicians. These services are designed to address the unique needs of their clients while fostering a strengths-based approach to care. Avela Health aims to provide clarity and support to individuals and families navigating the complexities of autism and related conditions.
Their services are primarily offered in New Jersey and North Carolina, catering to a diverse client base that includes neurodivergent individuals and their families seeking personalized and evidence-based interventions. Avela Health generates revenue through a structured transaction model that includes direct-to-consumer services and partnerships with healthcare providers. Clients can access a range of services, including virtual evaluations and ongoing therapy, typically compensated through insurance reimbursement or private pay options. The company accepts several insurance plans, including Horizon Blue Cross Blue Shield in New Jersey and North Carolina, ensuring coverage for their comprehensive autism evaluations and therapeutic interventions.
Avela Health's pricing structure reflects the value of their specialized care, which is designed to integrate seamlessly into clients' daily routines, thereby enhancing the effectiveness of the support provided. Their flagship offerings center around the delivery of personalized, evidence-based interventions that extend beyond traditional therapy models, further solidifying their position in the market. Avela Health is poised for growth with plans to expand its service offerings and reach new geographic regions by 2025. The recent funding round, concluded on 2025-12-17, will be utilized to further develop their product lines and enhance their operational capabilities.
By targeting areas with a high demand for autism support services, Avela Health aims to broaden its impact and reach more individuals and families in need of tailored interventions.
Current Investors
Rethink Capital Partners, Montage Ventures, Black Jays Investments
Primary Industry
Healthcare Specialists
Sub Industries
Mental Health Services, Healthcare Specialists, Medical Software
Website
www.joinavela.com
Verticals
Cloud Computing, HealthTech, Mobile Apps
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.